Literature DB >> 8465942

N-isopropyliodoacetamide in the reduction and alkylation of proteins: use in microsequence analysis.

H C Krutzsch1, J K Inman.   

Abstract

A new reagent, N-isopropyliodoacetamide (NIPIA), for alkylation of sulfhydryl groups on proteins for microdigestion and microsequencing is described. The utility of this reagent in both of these procedures has been demonstrated. NIPIA was shown to be especially useful in microsequence analysis, where it yields high sensitivity in detection of Cys residues. This is because the phenylthiohydantoin (PTH) derivative of NIPIA-alkylated cysteine [PTH-Cys(NIPCAM)] appears as a sharp peak in a standard reverse-phase HPLC analysis of PTH amino acids, and elutes between PTH-Tyr and PTH-Pro where no other peaks are present. Thus the use of NIPIA circumvents various problems associated with HPLC analysis of PTH-Cys when other commonly used agents are employed for sulfhydryl alkylation, such as coeluting peaks or low signal levels. Procedures for the synthesis of NIPIA and other analogs, as well as PTH-Cys(NIPCAM), are also presented, and HPLC retention times for their corresponding PTH-Cys derivatives are compared.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465942     DOI: 10.1006/abio.1993.1089

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  BSF binds specifically to the bicoid mRNA 3' untranslated region and contributes to stabilization of bicoid mRNA.

Authors:  R Mancebo; X Zhou; W Shillinglaw; W Henzel; P M Macdonald
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Analysis of cysteine residues in peptides and proteins alkylated with volatile reagents.

Authors:  J E Hale; J P Butler; R R Pourmand
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

3.  Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation.

Authors:  C Béraud; W J Henzel; P A Baeuerle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.

Authors:  C Lapham; B Golding; J Inman; R Blackburn; J Manischewitz; P Highet; H Golding
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Cloning and expression of the gene for the active PPi-dependent phosphofructokinase of Entamoeba histolytica.

Authors:  Z Deng; M Huang; K Singh; R A Albach; S P Latshaw; K P Chang; R G Kemp
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

6.  Moesin functions as a lipopolysaccharide receptor on human monocytes.

Authors:  Z N Tohme; S Amar; T E Van Dyke
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Smaug, a novel and conserved protein, contributes to repression of nanos mRNA translation in vitro.

Authors:  C A Smibert; Y S Lie; W Shillinglaw; W J Henzel; P M Macdonald
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

8.  Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor.

Authors:  M S Jiang; Q Q Tang; J McLenithan; D Geiman; W Shillinglaw; W J Henzel; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Scythe: a novel reaper-binding apoptotic regulator.

Authors:  K Thress; W Henzel; W Shillinglaw; S Kornbluth
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

10.  Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.

Authors:  B Golding; J Inman; P Highet; R Blackburn; J Manischewitz; N Blyveis; R D Angus; H Golding
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.